1.4. Analysis.
Comparison 1: Effect of immunotherapy for surgically treated NSCLC patients: main analyses, Outcome 4: Overall survival rate, 2‐year
Comparison 1: Effect of immunotherapy for surgically treated NSCLC patients: main analyses, Outcome 4: Overall survival rate, 2‐year